Peptides for Cognitive Function & Focus: What’s Actually Studied
A plain-language guide to “nootropic peptides:” What’s been tested in people, what’s only been tested in animals, and how each one is sold.
A handful of peptides get talked about for focus, memory, and calm. Peptides are short chains of amino acids, the same building blocks that make up proteins. And the best known for focus, memory and calm are Semax and Selank, two nasal sprays developed in Russia, where they’re sold as approved medicines . As of September 2026, none of the peptides on this page is FDA-approved for any use in the US. The human evidence is mostly small studies from one country, and several of the others, like Dihexa and P21, have only been tested in animals.
So if you’re looking for “peptides for brain function” with strong human evidence behind them, there aren’t any yet. What you’ll find below is where each compound actually stands: what it has been studied for, how good that evidence is, its US regulatory status, and who really sells it.
What “cognitive peptides” actually means
“Cognitive peptides” (you’ll also see “nootropic peptides,” from nootropic, meaning a substance claimed to support thinking or memory) is a marketing label. It isn’t a medical category. It covers two different kinds of compounds.
The first kind are copies of small pieces of molecules your body already uses to send signals. Semax is modeled on a fragment of ACTH, a stress hormone your pituitary gland releases. Selank is modeled on tuftsin, a tiny peptide your immune system makes.
The second kind are lab-built molecules that only imitate peptides. Scientists call these peptidomimetics, meaning molecules designed to act like a peptide without being a true one. Dihexa and P21 fall into this group, and one popular compound, Noopept, isn’t a peptide at all. If you want the basics first, start with what peptides are and how they work.
The evidence at a glance
This table shows the strongest evidence for each compound and how it’s really sold in the US. For live status updates, see each compound’s row on our Regulatory Tracker.
| Compound | What it’s studied for | Best evidence so far | Approved anywhere? | US status (as of Sept 2026) | How it’s actually sold in the US |
|---|---|---|---|---|---|
| Semax | Stroke recovery, attention, memory | Small human studies, almost all Russian | Russia [VERIFY against primary source] | Not FDA-approved; not yet eligible for compounding (PCAC recommended adding it, July 2026) | “Research use only” websites; some telehealth clinics; foreign pharmacies |
| Selank | Anxiety, calm focus | Small human studies, Russian only | Russia [VERIFY against primary source] | Not FDA-approved; not on FDA’s list of substances pharmacies may compound [VERIFY: Selank’s current FDA 503A category against FDA’s categories PDF before publish] | “Research use only” websites; some telehealth clinics; foreign pharmacies |
| Dihexa | Memory, dementia | Animal and lab only; no human trials | Nowhere | Not FDA-approved; not eligible for compounding | “Research use only” websites |
| P21 (P021) | Memory, Alzheimer’s-like changes | Mouse studies only | Nowhere | Experimental research compound; not eligible for compounding | “Research use only” websites |
| Cerebrolysin | Stroke, dementia, brain injury | Human trials, with mixed results | Parts of Europe and Asia [VERIFY against primary source] | Not FDA-approved | Foreign pharmacies / personal import |
| Cortexin | Stroke, brain function | Very thin; mostly Russian | Russia [VERIFY against primary source] | Not approved; not eligible for compounding | Foreign pharmacies / personal import |
| Pinealon | “Brain aging” | Very thin; mostly one research group | No confirmed approval | Not approved; not eligible for compounding | “Research use only” websites |
| Noopept (not a peptide) | Memory, focus | Limited | Russia [VERIFY against primary source] | Not FDA-approved; FDA treats it as an unapproved drug when sold with health claims | Supplement-style online sellers |
One thing stands out in the table: none of these compounds has a large, well-controlled human trial behind it for focus or memory in healthy people. [CITE: ClinicalTrials.gov search results for Semax, Selank, Dihexa, and Cerebrolysin showing whether any trials are registered at US sites]
Semax: the focus and stroke-recovery peptide
Semax is a nasal spray developed in Russia and sold there as a medicine, mainly for stroke recovery and some memory and attention problems [VERIFY against primary source]. The human evidence is small and almost entirely Russian. [CITE: Russian clinical study of Semax in ischemic stroke (candidate: PubMed 29798983, “The efficacy of semax in the treatment of patients at different stages of ischemic stroke”), plus any review of Semax human studies]
Semax is built from a short piece of ACTH, the stress hormone, with a few extra amino acids added so your body doesn’t break it down right away. In animal studies, researchers have linked it to higher levels of the brain’s own growth signals. Those are proteins that help nerve cells survive and form connections. Whether that turns into better focus in a healthy person hasn’t been shown.
Here’s the regulatory status, and it’s easy to misread. Semax is not FDA-approved for any use and is not currently eligible for compounding under federal law, as of September 2026. FDA took it off its “do not compound” list (called Category 2) in April 2026 after its nomination was withdrawn. Then, in July 2026, FDA’s Pharmacy Compounding Advisory Committee (PCAC) voted to recommend adding Semax to the list of substances pharmacies may compound. That recommendation doesn’t take effect until FDA finishes formal rulemaking, so Semax isn’t compoundable yet.
You’ll also see a variant called N-acetyl semax amidate. It’s a chemically modified version sold on research-chemical websites, and no country has approved it. For more detail, see our Semax entry and Semax vs. Selank
Selank and peptides for anxiety
Selank is the peptide most often searched for anxiety. It’s a Russian-developed nasal spray approved there for anxiety, and the human evidence comes from small Russian trials. It’s studied for anxiety. It is not FDA-approved for anxiety or for anything else.
Selank is modeled on tuftsin, the small immune-system peptide, with a few amino acids added to make it last longer in the body. Russian researchers suggest it affects brain chemicals involved in mood and stress, but that mechanism mostly comes from animal work.
The best-known human study compared Selank with a benzodiazepine, a standard type of prescription anti-anxiety drug, in people with generalized anxiety disorder (constant, hard-to-control worry). [CITE: Zozulia et al., 2008, Selank vs. benzodiazepine in generalized anxiety disorder (candidate: PubMed 18454096); abstract details not yet confirmed] The researchers reported similar anxiety relief with fewer side effects. The study was small and came from a single country, and it hasn’t been repeated by independent groups elsewhere. That’s promising, but it’s a long way from settled.
Selank is not FDA-approved for any use and is not on FDA’s list of substances pharmacies may compound, as of September 2026. [VERIFY: Selank’s current FDA 503A category against FDA’s categories PDF before publish] Unlike Semax, it wasn’t on the July 2026 advisory-committee agenda. See our Selank entry.
Dihexa and P21: big claims, animal-only evidence
Dihexa and P21 draw some of the loudest claims online, and they have the least human evidence behind them. Neither has ever been tested in a human trial. Everything known about them comes from lab dishes and rodents.
Dihexa is a lab-made molecule based on a fragment of angiotensin, a hormone best known for controlling blood pressure. The “stronger than BDNF” claim you’ll see comes from lab experiments. BDNF is one of the brain’s own growth signals, and the claim is that Dihexa out-performed it at helping nerve cells form connections in a dish. The main rat study was published in 2013 (McCoy et al., J Pharmacol Exp Ther). In 2021, the journal attached a formal “Notice of Concern” to that paper, which means the editors flagged questions about it. That’s worth knowing when you see the study quoted as proof.
Dihexa works through a growth signal called HGF, which helps many kinds of cells grow and repair. Researchers have raised an open question about whether boosting a cell-growth pathway could also affect cancer risk. Nobody has studied this in people, so it’s an unknown, not a demonstrated risk. That’s also true of Dihexa’s safety in people in general.
Dihexa is not FDA-approved and has never been tested in human trials. It’s not eligible for compounding, as of September 2026. FDA removed it from Category 2 in April 2026, and its advisory-committee review is scheduled before the end of February 2027.
P21 (also written P021) is a lab-made molecule designed to imitate part of a natural nerve-growth protein. Mouse studies from one research group reported less memory decline in mice bred to develop Alzheimer’s-like brain changes. [CITE: P021 mouse study from the Iqbal lab (candidate: PubMed 25046994)] P21 is an experimental research compound that is not approved or eligible for compounding anywhere, as of September 2026. See the Dihexa and P21 entries
Cerebrolysin, Cortexin and Pinealon: the brain-extract and “bioregulator” group
These three come from a different tradition: extracts from animal brains, plus short lab peptides that Russian researchers call “bioregulators,” meaning small peptides they believe help specific organs work normally. The evidence ranges from mixed (Cerebrolysin) to very thin (Cortexin and Pinealon).
Cerebrolysin is a mixture of peptides processed from pig brain and given by injection or IV drip. It’s a prescription drug in parts of Europe and Asia [VERIFY against primary source], but it is not FDA-approved in the US, as of September 2026. It has the most human data in this group, and the results aren’t encouraging for its best-known use.
A 2023 Cochrane review looked at seven randomized trials, with 1,773 people who had just had a stroke caused by a blocked artery. Cochrane is an independent group that pools trial results. The review found Cerebrolysin, or the similar extract Cortexin, probably makes little to no difference to the risk of dying. It also found a possible increase in serious side effects that weren’t fatal. The evidence for dementia is mixed. [CITE: systematic review of Cerebrolysin in dementia]
Cortexin is a similar extract from calf or pig brain, used mainly in Russia [VERIFY against primary source]. Pinealon is a very short lab-made peptide, only three amino acids long, promoted for “brain aging.” Most of its research comes from one Russian research group. [CITE: Khavinson review of peptide bioregulators (candidate: PubMed 24003726)] Cortexin and Pinealon are not approved in the US and not eligible for compounding, as of September 2026.
If “bioregulator peptides” are what brought you here, our Longevity & Anti-Aging hub covers the wider group. Entries for Cerebrolysin, Cortexin, and Pinealon are coming .
Often confused with peptides: Noopept
Noopept isn’t a peptide. It’s a small lab-made drug developed in Russia. Its name and marketing make it sound like part of this group, and people search for it alongside Semax and Selank, which is why it’s here.
In the US, Noopept is often sold like a dietary supplement. FDA doesn’t see it that way. Noopept is not FDA-approved, and FDA has treated it as an unapproved drug, not a legal dietary supplement, when it’s sold with health claims. That position appears in its 2019 warning letters, such as the one to Peak Nootropics, and still stands as of September 2026. How these are actually sold in the US, and what that means for you
You won’t find any of these compounds at a regular US pharmacy. The main real-world source for Semax, Selank, Dihexa, P21, and Pinealon is “research use only” websites that sell nasal sprays, powders, or sometimes capsules directly to consumers. That label means there’s no prescription and no medical supervision. There’s also no FDA oversight of how the product is made. Nobody checks that the vial contains what the label says, or how much of it. You also have no legal protection if something goes wrong.
Some telehealth and wellness clinics market Semax and Selank with a prescription. A licensed clinician may write that prescription, but the pharmacy filling it would be compounding a substance that isn’t eligible for compounding yet, as of September 2026. A prescription gives you medical supervision. It doesn’t make the product FDA-approved or change its status.
Compounding pharmacies can’t legally make any of these right now. If FDA finalizes the PCAC recommendation, Semax could become the exception. A licensed pharmacist would then be accountable for what’s in the vial, but it still wouldn’t be an FDA-approved drug.
Cerebrolysin, Cortexin, and Russian-made Semax and Selank also reach the US through foreign pharmacies and personal import. Those products are made under another country’s drug regulator. Bringing in drugs that aren’t FDA-approved can run into US import rules, and counterfeits are a real risk. Noopept is mostly sold by supplement-style sellers, with nobody checking what’s in it or how much.
None of this tells you a compound is safe because someone will ship it to you. It doesn’t tell you it’s dangerous, either. It tells you who’s accountable for what’s in the product, which for most of this list is no one.
What users report vs. what the studies show
If you’ve read forums or heard podcasts, you’ve seen people describe sharper focus, calmer moods, or better memory on Semax or Selank. Those reports are real experiences. They just aren’t reliable evidence that the compound caused the effect.
Focus and calm are especially easy to be fooled about. They change from day to day with sleep, caffeine, stress, and mood. If you expect a spray to help, you’ll often feel sharper anyway. That’s called the placebo effect, and it’s strongest for subjective feelings like “clearer thinking.” People also tend to post about what worked and quietly drop what didn’t.
A convincing trial would randomly assign people to the real compound or a look-alike dummy, with neither the participants nor the researchers knowing who got which. It would measure focus and memory with objective tests, not just self-ratings, and it would be repeated by independent teams in more than one country. None of the compounds on this page has cleared that bar for focus in healthy adults.
Related categories
Several compounds people ask about here belong to neighboring hubs:
- Sleep: DSIP, often called a “sleep peptide,” and the calming side of Selank. See Peptides for Sleep
- Longevity & Anti-Aging: Epitalon, Pinealon, and the wider bioregulator group. See Peptides for Longevity [LINK PENDING: page not yet live; confirm slug] and the Epitalon entry
- Tissue Repair & Recovery: the “does BPC-157 help the brain?” question, plus Cerebrolysin’s use after brain injury. See Peptides for Tissue Repair
- Muscle growth: a separate topic, covered in Peptides for Muscle Growth.
FAQs about peptides for cognitive function
Is Semax FDA-approved?
No. Semax is not FDA-approved for any use and is not currently eligible for compounding under federal law, as of September 2026. An FDA advisory committee recommended in July 2026 that pharmacies be allowed to compound it, but that doesn’t take effect until FDA completes formal rulemaking.
Is Selank legal in the US?
Selank is not FDA-approved for any use and is not on FDA’s list of substances pharmacies may compound, as of September 2026. In practice, it’s mostly sold by “research use only” websites with no prescription, no medical oversight, and no check on what’s actually in the vial. [VERIFY: Selank’s current FDA 503A category against FDA’s categories PDF before publish]
What’s the best peptide for brain function?
None has strong human evidence yet. Semax and Selank have the most human data, but it comes from small studies, almost all from Russia. Dihexa and P21 have only been tested in animals, and none of these is FDA-approved, as of September 2026.
Are peptides good for ADHD?
No peptide has been shown to help ADHD in well-designed human trials, and none is FDA-approved for it, as of September 2026. If you’re managing ADHD, talk to a licensed clinician about options that have been properly tested.
Is Noopept a peptide?
No. Noopept is a small lab-made drug, not a peptide, even though it’s often marketed alongside them. It’s not FDA-approved, and FDA has treated it as an unapproved drug when it’s sold with health claims, as of September 2026.
This article is for informational purposes only and isn’t medical advice. Talk to a licensed healthcare provider before using any peptide, especially one that’s unapproved or compounded. We don’t yet work with a credentialed medical reviewer — see our editorial policy for what that means for this article.
